<?xml version="1.0"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
<channel>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
<description>BloggingStocks</description>
<image>
<url>http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif</url>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
</image>
<language>en-us</language>
<copyright>Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only.</copyright>
<generator>Blogsmith http://www.blogsmith.com/</generator><item><title><![CDATA[Amgen Boosted by Upbeat Drug Data]]></title><link>http://www.bloggingstocks.com/2010/12/14/amgen-boosted-by-upbeat-drug-data/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2010/12/14/amgen-boosted-by-upbeat-drug-data/</guid><comments>http://www.bloggingstocks.com/2010/12/14/amgen-boosted-by-upbeat-drug-data/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/major-movement/" rel="tag">Major Movement</a>, <a href="http://www.bloggingstocks.com/category/analyst-upgrades-and-downgrades/" rel="tag">Analyst Upgrades and Downgrades</a>, <a href="http://www.bloggingstocks.com/category/amgn/" rel="tag">Amgen Inc (AMGN)</a>, <a href="http://www.bloggingstocks.com/category/analysis/" rel="tag">Technical Analysis</a></p><p><img vspace="4" hspace="4" border="1" align="right" alt="Amgen (AMGN) logo" src="http://www.blogcdn.com/www.bloggingstocks.com/media/2010/12/amgenlogo.jpg" />Late Monday, Amgen (<a class="inlinked" href="http://www.dailyfinance.com/quotes/amgen-inc/amgn/nas">AMGN</a>) unveiled positive results for its bone drug, denosumab. A <a href="http://online.wsj.com/article/BT-CO-20101213-714582.html">clinical study of 1,432 men</a> with hormone refractory prostate cancer revealed that denosumab, which is also known as Xgeva, improved bone metastasis-free survival by 4.2 months. However, the overall survival rate was comparable to a placebo group.</p>
<p>Denosumab is already used to treat osteoporosis under the brand name Prolia, and has been approved under the brand name Xgeva for the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors. The drug has not yet been approved for the prevention of SREs in multiple myeloma patients.</p><p><a href="http://www.bloggingstocks.com/2010/12/14/amgen-boosted-by-upbeat-drug-data/" rel="bookmark">Continue reading <em>Amgen Boosted by Upbeat Drug Data</em></a></p><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2010/12/14/amgen-boosted-by-upbeat-drug-data/">Amgen Boosted by Upbeat Drug Data</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Tue, 14 Dec 2010 11:30:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2010/12/14/amgen-boosted-by-upbeat-drug-data/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/19760097/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2010/12/14/amgen-boosted-by-upbeat-drug-data/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>Amgen</category><category>Amgen rally</category><category>Amgen upgrade</category><category>AMGN</category><category>clinical study</category><category>denosumab</category><category>drug trial</category><category>featured</category><category>inthenews</category><category>Piper Jaffray</category><category>Prolia</category><category>technical analysis</category><category>upgrade</category><category>Xgeva</category><dc:creator><![CDATA[Elizabeth Harrow]]></dc:creator><pubDate>Tue, 14 Dec 2010 11:30:00 EST</pubDate></item><item><title><![CDATA[Closing Bell: Deals drive home (AMGN, S, IPCS, CIT, FNM, FRE)]]></title><link>http://www.bloggingstocks.com/2009/10/19/closing-bell-deals-drive-home-amgn-s-ipcs-cit-fnm-fre/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2009/10/19/closing-bell-deals-drive-home-amgn-s-ipcs-cit-fnm-fre/</guid><comments>http://www.bloggingstocks.com/2009/10/19/closing-bell-deals-drive-home-amgn-s-ipcs-cit-fnm-fre/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/s/" rel="tag">Sprint Nextel Corp (S)</a>, <a href="http://www.bloggingstocks.com/category/cit/" rel="tag">CIT Group (CIT)</a>, <a href="http://www.bloggingstocks.com/category/fnm/" rel="tag">Federal Natl Mtge (FNM)</a>, <a href="http://www.bloggingstocks.com/category/amgn/" rel="tag">Amgen Inc (AMGN)</a></p><img hspace="4" border="1" align="right" vspace="4" src="http://www.blogcdn.com/www.bloggingstocks.com/media/2007/08/bell-green.jpg" alt="" />Despite a <a href="http://247wallst.com/2009/10/19/homebuilders-already-cautious-get-more-cautious-xhb-itb/">cautious report</a> from home builders and despite a low volume day, today marked a clear win for the S&amp;P 5000 and for the DJIA. The S&amp;P broke through 1,100 and the DJIA broke through 11,000. We also had two mergers this morning, and while small they are signs that companies are willing to merge once more. <br /><br />Here were today's closing bell levels:<br /><br />Dow 	10,090.76 	+94.85 	(0.95%) <br />S&amp;P 500 	1,097.52 	+9.84 	(0.90%) <br />Nasdaq 	2,175.83 	+19.03 	(0.88%)<br /><br /><a href="http://247wallst.com/2009/10/19/top-10-analyst-upgrades-downgrades-initiations-acn-aai-cfn-fslr-fnm-fre-gern-mrvl-luv-tlab/">Top 10 Analyst Calls</a><br /><a href="http://247wallst.com/2009/10/19/top-day-trader-alerts-alli-ipcs-fnm-fre-amgn-cit/">Top Day Trader Alerts</a><br /><a href="http://247wallst.com/2009/10/19/todays-best-market-rumors-10192009-potsymccmeaapl/">Top Stock Rumors </a><p><a href="http://www.bloggingstocks.com/2009/10/19/closing-bell-deals-drive-home-amgn-s-ipcs-cit-fnm-fre/" rel="bookmark">Continue reading <em>Closing Bell: Deals drive home (AMGN, S, IPCS, CIT, FNM, FRE)</em></a></p><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2009/10/19/closing-bell-deals-drive-home-amgn-s-ipcs-cit-fnm-fre/">Closing Bell: Deals drive home (AMGN, S, IPCS, CIT, FNM, FRE)</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Mon, 19 Oct 2009 16:00:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2009/10/19/closing-bell-deals-drive-home-amgn-s-ipcs-cit-fnm-fre/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/19201381/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2009/10/19/closing-bell-deals-drive-home-amgn-s-ipcs-cit-fnm-fre/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>carl icahn</category><category>CarlIcahn</category><category>complete response letter</category><category>CompleteResponseLetter</category><category>fda</category><category>FRE</category><category>IPCS</category><category>osteoporosis</category><category>prolia</category><dc:creator><![CDATA[Jon Ogg]]></dc:creator><pubDate>Mon, 19 Oct 2009 16:00:00 EST</pubDate></item></channel></rss>
